Global Oncology Ablation Market

Oncology Ablation Market Size, Share, Growth Analysis, By Type of Ablation (Radiofrequency Ablation (RFA), Microwave Ablation (MWA)), By Procedure Type (Minimally Invasive Ablation, Surgical Ablation), By Application (Liver Cancer, Lung Cancer), By End User, By Region - Industry Forecast 2026-2033

Report ID: SQSG35B2038 | Region: Global | Published Date: November, 2025
Pages: 225 | Tables: 93 | Figures: 67

Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Oncology Ablation Market size was valued at USD 1.5 Billion in 2024 and is poised to grow from USD 1.7 Billion in 2025 to USD 4.72 Billion by 2033, growing at a CAGR of 13.6% during the forecast period (2026–2033).

    Global Oncology Ablation Market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Angiodynamics (Covidien) (US) ', 'Boston Scientific Corporation (US) ', 'Medtronic Plc (US) ', 'Ethicon, Inc. (US) ', 'Galil Medical Inc. (US) ', 'Misonix Inc. (US) ', 'HealthTronics (US) ', 'Mermaid Medical (Denmark) ', 'Theraclion (France) ', 'Chongqing Haifu Medical Technology Co., Ltd. (China) ', 'HS Hospital Service S.P.A (Italy) ', 'Hologic, Inc. (US) ', 'Varian Medical Systems (US) ', 'Cook Medical (US) ', 'LeVeen Medical (US) ', 'Integra LifeSciences (US) ', 'MedWaves, Inc. (US) ', 'Sanarus Technologies, Inc. (US) ', 'Bovie Medical Corporation (US) ', 'ThermoLife (US)'

    The demand for advanced tumour ablation techniques is anticipated to increase throughout the forecast period as surgeons and patients become more inclined toward minimally invasive procedures due to the advantages of quick recovery, patient comfort, and shorter recovery times.

    Cooled Radiofrequency Probes Gaining Traction: Market player are focusing on technological advancements to improve accuracy, portability, and cost-effectiveness. HIFU, cryoablation, and image-guided equipment are three prominent examples of these technological developments. One of the upcoming approaches that is projected to significantly contribute to market growth is the use of the cooled radiofrequency denervation technique with internally cooled radiofrequency probes to increase the size of the lesion. This procedure makes it possible to completely denervate the sacroiliac joint, which aids in the treatment of pain.

    North America dominated the global market with a revenue share of over 30.1% in 2021. Government support for high-quality healthcare, high purchasing power parity, the availability of reimbursements, and the rising incidence of cancer are some of the main drivers of this region's growth. The Patient Protection and Affordable Care Act (PPACA), for instance, lowers the cost of healthcare for both individuals and the government in the United States by promoting the quality and accessibility of healthcare through health coverage policies. Another important growing component is the precision medicine project, which develops personalised solutions for particular illness characteristics. Therefore, it is projected that such government initiatives will enhance the healthcare system as a whole, thereby spurring market growth.

    Related Reports

    Tumor Ablation Market
    Buy Now GET FREE SAMPLE
    Ablation Devices Market
    Buy Now GET FREE SAMPLE
    Cardiac Ablation Market
    Buy Now GET FREE SAMPLE
    Oncology Market
    Buy Now GET FREE SAMPLE
    Oncology Drugs Market
    Buy Now GET FREE SAMPLE
    Endometrial Ablation Market
    Buy Now GET FREE SAMPLE
    MRI-Guided Neurosurgical Ablation Market
    Buy Now GET FREE SAMPLE
    Cancer Biological Therapy Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Oncology Ablation Market

    Report ID: SQSG35B2038

    $5,300
    BUY NOW GET FREE SAMPLE